Rubella Seroprevalence Boost in the Pediatric and Adolescent Population of Florence (Italy) as a Preventive Strategy for Congenital Rubella Syndrome (CRS).
Beatrice ZanellaSara BoccaliniBenedetta BonitoMarco Del RiccioFederico ManziEmilia TiscionePaolo BonanniWorking Group DhsWorking Group AOUMeyerWorking Group AusltcAngela BechiniPublished in: Vaccines (2020)
Our study showed the highest seroprevalence rate reached in the province of Florence for rubella in the last 15 years, thanks to the several successful vaccination campaigns promoted in the Tuscany region. Our findings in pediatric and adolescent subjects are a key factor in preventing CRS in adult life, specifically in childbearing women. Thus, the set goal will be to keep the awareness about the vaccination for this preventable disease high.